Prosecution Insights
Last updated: August 17, 2026

Examiner: RODRIGUEZ-GARCIA, VALERIE

Tech Center 1700 • Art Units: 1600 1621 1622 1626 1759

This examiner grants 69% of resolved cases

Performance Statistics

68.8%
Allow Rate
+3.8% vs TC avg
861
Total Applications
+31.9%
Interview Lift
900
Avg Prosecution Days
Based on 829 resolved cases, 2023–2026

Rejection Statute Breakdown

3.0%
§101 Eligibility
22.5%
§102 Novelty
22.3%
§103 Obviousness
38.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18661776 SKIN CARE COMPOSITION COMPRISING HYDROXYCINNAMIC ACID AND NIACINAMIDE DERIVATIVE Non-Final OA The Procter & Gamble Company
18019501 USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS VIII Non-Final OA BASF SE
17997872 FUNGICIDAL COMPOSITIONS Final Rejection SYNGENTA CROP PROTECTION AG
17771732 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES Non-Final OA Bayer Aktiengesellschaft
18184249 METHOD FOR DETECTION OF MICROORGANISMS Final Rejection Ramot at Tel-Aviv University Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month